VIE - Viela Bio Inc. (VIE) CEO Bing Yao on Q4 2019 Results - Earnings Call Transcript
Viela Bio, Inc. (VIE)
Q4 2019 Earnings Conference Call
March 25, 2020 5:00 P.M. ET
Company Participants
Mitchell Chan - Chief Financial Officer
Bing Yao - Chairman and Chief Executive Officer
Jorn Drappa - Chief Medical Officer, Head of Research and Development
Bill Ragatz - Vice President, Head of Commercial
Conference Call Participants
Seamus Fernandez - Guggenheim Securities, LLC
Jeff Hung - Morgan Stanley
Paul Choi - Goldman Sachs
Chris Shibutani - Cowen and Company
Raghuram Selvaraju - H.C. Wainwright & Co.
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Viela Bio